Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Mean Arterial Pressure (MAP) Calculator
Collaborate
About
EQOH
Careers
Contact Us
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Mean Arterial Pressure (MAP) Calculator
Collaborate
About
EQOH
Careers
Contact Us
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
Join
FREE
Edition
European
US
Rheumatology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
TLR7/8 Inhibitor Reduces Cutaneous Disease Activity in SLE
May 2026
Researchers reported significant dose-dependent improvements in lupus skin disease activity with the oral TLR7/8 inhibitor enpatoran.
Read more
20 Jun 2025
Over 40% of Lupus Patients Lack Enough Exercise
An international study shows that many people with lupus are not physically active enough, with low activity levels linked to worse fatigue, stress, and depression.
14 Jun 2025
EULAR 2025: Five Distinct Phenotypes Identified in Behçet’s Syndrome Using AI-Powered Clustering
A new EULAR 2025 study has redefined Behçet’s syndrome subtypes using latent class analysis, revealing five unique phenotypes that may inform personalized treatment strategies.
13 Jun 2025
EULAR 2025: Single-Cell Study Reveals Pro-Inflammatory Fibroblast Signature in Very Early Systemic Sclerosis
A new study from EULAR 2025 shows that patients with very early systemic sclerosis have a distinct pro-inflammatory fibroblast profile before any signs of fibrosis appear.
12 Jun 2025
EULAR 2025: MONITOR-PsA Study Confirms Feasibility of Treat-to-Target in Routine Practice
A new analysis from the MONITOR-PsA study, presented at EULAR 2025, demonstrates that a pragmatic treat-to-target (T2T) approach in psoriatic arthritis leads to promising clinical outcomes over 48 weeks.
11 Jun 2025
EULAR 2025: MRI Detects Early Spinal Changes in axSpA
Presented at EULAR 2025, new 2-year data from the SPACE cohort show that spinal fat lesions on MRI progress in early axial spondyloarthritis, unlike in non-axSpA chronic back pain.
29 May 2025
Study Links Autoantibodies to Lung Fibrosis Risk
Patients with anti-synthetase syndrome-associated interstitial lung disease show distinct lung imaging and clinical profiles depending on their antibody type, according to a new study.
21 May 2025
Study Identifies Flare Risk in Rheumatoid Arthritis Remission
The UK BIO-FLARE study finds that half of rheumatoid arthritis patients relapse after stopping medication, with flare risk predicted by baseline clinical factors.
19 May 2025
Exercise Found to Reduce Risk of Developing Lupus
A large UK-based study has shown that individuals engaging in regular physical activity have a significantly lower risk of developing systemic lupus erythematosus, with benefits varying by age and sex.
Loading posts...
« Previous
1
…
11
12
13
14
15
…
44
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View